Growth Metrics

Mannkind (MNKD) Enterprise Value (2010 - 2026)

Mannkind (MNKD) reported Enterprise Value of -$134.6 million for Q1 2026, up 26.15% year-over-year from -$106.7 million in Q1 2025, and up 21.44% on a QoQ basis from -$171.3 million in Q4 2025.

Mannkind (MNKD) has 17 years of Enterprise Value data on file, last reported at -$134.6 million in Q1 2026.

  • Quarterly Enterprise Value rose 26.15% year-over-year to -$134.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$134.6 million (up 26.15% YoY) and the FY2025 annual result came in at -$171.3 million, up 13.46% from the prior year.
  • Enterprise Value rose to -$134.6 million in Q1 2026 per MNKD's latest filing, from -$171.3 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$134.6 million in Q1 2026 and bottomed at -$300.7 million in Q1 2024.
  • The 5-year median for Enterprise Value is -$171.3 million (2025), against an average of -$195.6 million.
  • The widest annual swing landed in 2022, when Enterprise Value surged 41.34%; it then tumbled 81.01% in 2024.
  • Tracing MNKD's Enterprise Value over 5 years: stood at -$170.8 million in 2022, then sank by 72.73% to -$295.1 million in 2023, then surged by 32.91% to -$198.0 million in 2024, then climbed by 13.46% to -$171.3 million in 2025, then climbed by 21.44% to -$134.6 million in 2026.
  • Per Business Quant, the three latest MNKD Enterprise Value figures stand at -$134.6 million (Q1 2026), -$171.3 million (Q4 2025), and -$260.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -2.32 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -32.30 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -286.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -61.46 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -2.77 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -7.25 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -18.44 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -8.75 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -3.01 Bn
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn -134.61 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -134.61 Mn
Dec 31, 2025 -171.35 Mn
Sep 30, 2025 -260.04 Mn
Jun 30, 2025 -178.99 Mn
Mar 31, 2025 -182.28 Mn
Dec 31, 2024 -197.99 Mn
Sep 30, 2024 -252.32 Mn
Jun 30, 2024 -248.49 Mn
Mar 31, 2024 -300.73 Mn
Dec 31, 2023 -295.10 Mn
Sep 30, 2023 -141.02 Mn
Jun 30, 2023 -144.35 Mn
Mar 31, 2023 -166.14 Mn
Dec 31, 2022 -170.85 Mn
Sep 30, 2022 -165.05 Mn
Jun 30, 2022 -154.15 Mn
Mar 31, 2022 -162.40 Mn
Dec 31, 2021 -204.12 Mn
Sep 30, 2021 -139.01 Mn
Jun 30, 2021 -162.47 Mn
Mar 31, 2021 -276.83 Mn
Dec 31, 2020 -67.16 Mn
Sep 30, 2020 -52.71 Mn
Jun 30, 2020 -63.54 Mn
Mar 31, 2020 -38.87 Mn
Dec 31, 2019 -49.91 Mn
Sep 30, 2019 -50.06 Mn
Jun 30, 2019 -13.28 Mn
Mar 31, 2019 -59.29 Mn
Dec 31, 2018 -71.68 Mn
Sep 30, 2018 -10.97 Mn
Jun 30, 2018 -26.71 Mn
Mar 31, 2018 -27.23 Mn
Dec 31, 2017 -48.36 Mn
Sep 30, 2017 -10.00 Mn
Jun 30, 2017 -43.38 Mn
Mar 31, 2017 -47.98 Mn
Dec 31, 2016 -22.90 Mn
Sep 30, 2016 -35.53 Mn
Jun 30, 2016 -63.73 Mn
Mar 31, 2016 -27.65 Mn
Dec 31, 2015 -59.07 Mn
Sep 30, 2015 -32.93 Mn
Jun 30, 2015 -107.19 Mn
Mar 31, 2015 -120.84 Mn
Dec 31, 2014 -120.84 Mn
Sep 30, 2014 -172.47 Mn
Jun 30, 2014 -41.21 Mn
Mar 31, 2014 -35.76 Mn
Dec 31, 2013 -70.79 Mn
Sep 30, 2013 -93.80 Mn
Jun 30, 2013 -28.53 Mn
Mar 31, 2013 -28.01 Mn
Dec 31, 2012 -61.84 Mn
Sep 30, 2012 -2.12 Mn
Jun 30, 2012 -31.99 Mn
Mar 31, 2012 -56.71 Mn
Dec 31, 2011 -3.20 Mn
Sep 30, 2011 -23.30 Mn
Jun 30, 2011 -25.27 Mn
Mar 31, 2011 -46.91 Mn
Dec 31, 2010 -70.43 Mn
Sep 30, 2010 -97.93 Mn
Jun 30, 2010 -28.36 Mn